L3VLUP
ProSign in

ATRC · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ATRCLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ATRC
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterATRCLLY
Q3 20203 holders, $30m33 holders, $14.1bn
Q4 20204 holders, $73m29 holders, $17.3bn
Q1 20215 holders, $254m24 holders, $23.0bn
Q2 20214 holders, $278m24 holders, $27.8bn
Q3 20214 holders, $273m31 holders, $29.9bn
Q4 20213 holders, $254m31 holders, $34.7bn
Q1 20223 holders, $268m24 holders, $35.3bn
Q2 20222 holders, $165m33 holders, $42.7bn
Q3 20223 holders, $162m31 holders, $43.4bn
Q4 20222 holders, $159m31 holders, $46.6bn
Q1 20233 holders, $155m33 holders, $44.3bn
Q2 20234 holders, $211m37 holders, $59.6bn
Q3 20234 holders, $201m44 holders, $67.6bn
Q4 20233 holders, $125m45 holders, $73.6bn
Q1 20242 holders, $140m41 holders, $95.3bn
Q2 20242 holders, $109m43 holders, $110bn
Q3 20244 holders, $151m45 holders, $107bn
Q4 20244 holders, $157m46 holders, $93.9bn
Q1 202510 holders, $284m42 holders, $98.4bn
Q2 20256 holders, $335m43 holders, $93.2bn
Q3 20254 holders, $290m39 holders, $86.7bn
Q4 20256 holders, $381m41 holders, $123bn
Q1 20263 holders, $178m39 holders, $106bn
Q2 20263 holders, $125m44 holders, $132bn
ATRC

Atricure Inc

Holders
4
Reported value
$157m
Buyers
1
Sellers
3

Breadth -2 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
46
Reported value
$93.9bn
Buyers
24
Sellers
23

Breadth +1 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2024

Among the 47 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ATRC (1)

PDT Partners LLC

Only LLY (43)

Acadian Asset Management LLC, AQR Capital Management LLC, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Egerton Capital UK LLP, Eisler Capital Management Ltd, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Lone Pine Capital LLC, Man Group PLC, Marshall Wace LLP, and 18 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →